Rani Therapeutics Holdings, Inc.RANINASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank40
3Y CAGR-31.4%
5Y CAGR-29.0%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-31.4%/yr
Annual compound
5Y CAGR
-29.0%/yr
Consistent
Percentile
P40
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 37.95 | - |
| 2023 | 0.00 | - |
| 2022 | 0.00 | -100.0% |
| 2021 | 117.55 | -73.7% |
| 2020 | 446.16 | +111.9% |
| 2019 | 210.55 | - |